International Chemical Entity Japan K.K.

The Bile Acids Expert

Other Manufacturing

Area Joban
Industrial ParksJoban Kashima Industrial Park

Products & Services

Other

Related Fields

Medical

Company Overview

ICE Japan manufactures and commercializes ursodeoxycholic acid (UDCA) active pharmaceutical ingredient for branded, generics and OTCproducts.
We supply both the Japanese and export markets.

Primary Products / Services

Ursodeoxycholic acid (UDCA) active pharmaceutical ingredient for branded, generics and OTC products

IP & Licenses, etc.

Certifications / Licenses
●ISO 14001 and ISO 45001 certified
●ISO 50001 To be certified in 2024

Company Strengths & Characteristics

ICE Japan is dedicated to the production of high-quality UDCA. It is an integrated manufacturing unit starting from cholic acid raw material.
The site is approved for supply to the Japanese, US, European and Chinese markets.
UDCA is a bile acid used for the treatment of primary biliary cirrhosis(PBC), dissolution of radiolucent gallstones in patients with a functioning gallbladder, and treatment of hepatobiliary disorders associated with cystic fibrosis in pediatric patients.

Future Prospects & Areas of Interest

ICE Group is a global company with a total of seven manufacturing facilities on the South North American continent, Europe, Asia, and Oceania. This large scale and flexible manufacturing capacity is fully utilized to achieve unparalleled high-quality manufacturing and stable supply chain management. ICE Group is also collaborating with some of the world’s leading universities and research institutions in medical research to conduct a variety of clinical trials using UDCA (ursodeoxycholic acid) to create medicines for multiple diseases and conditions for which no cure has been established. One of our future prospects is to further expand our business globally based on suchinnovation.

The Bile Acids Expert